The report on The Plasma Proteins Market in Canada – 2019/20 updates the same title published every two years. Two non-profit organizations (Canadian Blood Services and Héma-Québec) distribute most plasma and recombinant products, which distinguishes the market from other countries’. The effects of recent regulatory measures and on-going, economic and health care issues are examined in this report, which also provides sales data of all the major plasma-derived and recombinant proteins including non-factor hemophilia products.

The report is delivered electronically (Excel and/or pdf files). For more information or to order this report, please contact Marketing Research Bureau at inf0@marketingresearchburau.com

 

THE PLASMA PROTEINS MARKET IN CANADA
2019/2020

TABLE OF CONTENTS (2019/2020 Report)

EXECUTIVE SUMMARY.. 7
HEALTH CARE ENVIRONMENT. 19
BLOOD AND PLASMA COLLECTIONS. 19
Historical Development 19
Whole Blood Collections. 20
Plasma Procurement Plans. 21
Project Recovery. 22
Controversy around the Remuneration of Plasma Donations. 22
Canadian Blood Services (CBS) 23
Production and Distribution of Blood Components and Plasma Products. 25
Future Plans. 25
Héma-Québec (HQ) 26
Production and Distribution of Blood Components and Plasma Products. 27
Canadian Plasma Resources (CPR) 28
PLASMA FRACTIONATION.. 29
Historical Development 29
Contracts for Fractionation, Plasma products and Recombinant FVIII and FIX.. 29
Emergent BioSolutions (formerly Cangene Corporation) – Saol Therapeutics. 31
Liminal Biosciences (formerly Prometic Life Sciences) 33
Evolve Biologics (formerly Therapure Biopharma) 33
Green Cross Canada (Now part of Grifols) 34
MARKET OVERVIEW… 35
INTRAMUSCULAR IMMUNE GLOBULIN.. 36
Polyvalent Intramuscular Immune Globulin (IMIG) 36
Rho(D) Immune Globulin. 36
Hepatitis B Immune Globulin. 37
Rabies Immune Globulin. 38
Varicella Zoster Immune Globulin. 38
Cytomegalovirus Hyperimmune Globulin. 38
POLYVALENT IMMUNE GLOBULIN (IVIG & SCIG) 43
Intravenous Polyvalent Immune Globulin (IVIG) 45
Subcutaneous Polyvalent Immune Globulin (SCIG) 45
Canadian Self-Sufficiency. 46
2020 and COVID19 Effects on Canadian IG market 48
ALBUMIN MARKET. 53
HEMOPHILIA CARE AND COAGULATION MARKET. 54
Demographic Data on Hemophilia. 54
Hemophilia Treatment 54
Hemophilia A Market (FACTOR VIII) 55
Hemophilia B Market (FACTOR IX) Market 57
Von Willebrand Disease Market 67
Inhibitor Care Market 67
Factor VII 68
Factor XI 69
Factor XIII 69
OTHER PLASMA PRODUCTS. 70
Prothrombin Complex Concentrate Market (PCC) 70
Alpha-1 Antitrypsin (AAT) 70
Antithrombin III 70
C1 Esterase Inhibitor (C1-INH) 71
Fibrinogen. 71
Protein C.. 72
Fibrin Sealant 72
Plasminogen. 72
Hemin. 73
PRICING AND DISTRIBUTION.. 78
MARKET TRENDS AND THREE-YEAR FORECAST. 78
LIST OF MAJOR COMPANIES & ORGANIZATIONS. 79